期刊
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
卷 30, 期 1, 页码 126-130出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pnpbp.2005.08.016
关键词
double-blind study; prefrontal cortex; TMS-treatment; unipolar depression
Background: Transcranial magnetic stimulation (TMS) has become a therapeutic tool in psychiatric diseases. Methodology: The objective was to evaluate the efficacy of TMS in unipolar depression: the percentage of responders (> 50% HDRS reduction) and remission HDRS score <= 8, after four weeks of active TMS treatment in depressed patients free of any antidepressive agent versus placebo-TMS. Results: 27 patients were randomized in two groups: rTMS (N=11) versus sham TMS (N=16). Statistical differences were detected between sham and TMS treated groups on remission (0/16 versus 4/11 p=0.032, 1/16 versus 6/11 0.028 and 1/16 versus 7/11 p=0.011 at day 14, day 21 and day 28, respectively) and on response (2/16 versus 5/11 at day 14 (NS), 2/16 versus 7/11 p=0.0115 at day 21 and 1/16 versus 7/11 (p=0.025) day 28, respectively, using the exact Fisher test). Significant differences were observed between day 1 versus day 8 (p < 0.01), day 15, day 21 and day 28 (p < 0.001) in TMS group and only versus day 21 (p < 0.01) and day 28 (p < 0.05) for the sham group. ANOVA comparison between TMS and sham groups was significant at day 14 and day 28 (< 0.05). Limitations: The few number of patients. Conclusion: Our study has shown an efficacy of right rTMS in free medication unipolar depression over a month. Nevertheless, number of patients included is limited and multicentric studies will be necessary to specify the antidepressive action of TMS. (c) 2005 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据